Your browser doesn't support javascript.
HLA repertoire of 115 UAE nationals infected with SARS-CoV-2.
Alnaqbi, Halima; Tay, Guan K; Jelinek, Herbert F; Francis, Amirtharaj; Alefishat, Eman; El Haj Chehadeh, Sarah; Tahir Saeed, Amna; Hussein, Mawada; Mahboub, Bassam H; Uddin, Maimunah; Alkaabi, Nawal; Alsafar, Habiba S.
  • Alnaqbi H; Center for Biotechnology, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates; Department of Biomedical Engineering, College of Engineering, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates.
  • Tay GK; Center for Biotechnology, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates; Division of Psychiatry, Faculty of Health and Medical Sciences, the University of Western Australia, Crawley, Western Australia, Australia; School of Medical and Health Sciences, Edith Cowan Univ
  • Jelinek HF; Center for Biotechnology, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates; Department of Biomedical Engineering, College of Engineering, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates; Heath Engineering Innovation Center, Khalifa Universit
  • Francis A; Clinical Services, Medical Affairs, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
  • Alefishat E; Center for Biotechnology, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates; Department of Pharmacology, College of Medicine and Health Sciences, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates; Department of Biopharmaceutics & Clinical P
  • El Haj Chehadeh S; Center for Biotechnology, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates.
  • Tahir Saeed A; Dubai Health Authority, Rashid Hospital, Dubai, United Arab Emirates.
  • Hussein M; Dubai Health Authority, Rashid Hospital, Dubai, United Arab Emirates.
  • Laila Salameh; Dubai Health Authority, Rashid Hospital, Dubai, United Arab Emirates.
  • Mahboub BH; Dubai Health Authority, Rashid Hospital, Dubai, United Arab Emirates.
  • Uddin M; Department of Pediatric Infectious Disease, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
  • Alkaabi N; Department of Pediatric Infectious Disease, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
  • Alsafar HS; Center for Biotechnology, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates; Department of Biomedical Engineering, College of Engineering, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates; Department of Genetics and Molecular Biology, College
Hum Immunol ; 83(1): 1-9, 2022 Jan.
Article in English | MEDLINE | ID: covidwho-1719801
ABSTRACT
The class I and class II Human Leucocyte Antigens (HLA) are an integral part of the host adaptive immune system against viral infections. The characterization of HLA allele frequency in the population can play an important role in determining whether HLA antigens contribute to viral susceptibility. In this regard, global efforts are currently underway to study possible correlations between HLA alleles with the occurrence and severity of SARS-CoV-2 infection. Specifically, this study examined the possible association between specific HLA alleles and susceptibility to SARS-CoV-2 in a population from the United Arab Emirates (UAE). The frequencies of HLA class I (HLA-A, -B, and -C) and HLA class II alleles (HLA-DRB1 and -DQB1); defined using Next Generation Sequencing (NGS); from 115 UAE nationals with mild, moderate, and severe SARS-CoV-2 infection are presented here. HLA alleles and supertypes were compared between hospitalized and non-hospitalized subjects. Statistical significance was observed between certain HLA alleles and supertypes and the severity of the infection. Specifically, alleles HLA-B*5101 and HLA-A*2601 showed a negative association (suggestive of protection), whilst genotypes HLA-A*0301, HLA-DRB1*1501, and supertype B44 showed a positive association (suggestive of predisposition) to COVID-19 severity. The results support the potential use of HLA testing to differentiate between patients who require specific clinical management strategies.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 / HLA Antigens Type of study: Diagnostic study / Prognostic study Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Asia Language: English Journal: Hum Immunol Year: 2022 Document Type: Article Affiliation country: J.humimm.2021.08.012

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 / HLA Antigens Type of study: Diagnostic study / Prognostic study Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: Asia Language: English Journal: Hum Immunol Year: 2022 Document Type: Article Affiliation country: J.humimm.2021.08.012